Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

8.58
Delayed Data
As of Jul 02
 -0.07 / -0.81%
Today’s Change
6.61
Today|||52-Week Range
16.87
-29.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-44.2M-47.1M-58.9M-69.0M
 
 
 
 
 
Depreciation327.0K408.0K399.0K489.0K
 
 
 
 
 
Total Other Cash Flow3.4M3.6M4.9M8.3M
 
 
 
 
 
Funds From Operations-40.5M-43.1M-53.7M-60.2M
 
 
 
 
 
Funds From/For Other Operating Expenses-5.0M3.4M-19.0K-4.7M
 
 
 
 
 
Net Cash Flow - Operating Activities-35.6M-46.5M-53.6M-55.5M
 
 
 
 
 
 
InvestingIncrease In Investments-80.3M-79.8M-168.1M-79.3M
 
 
 
 
 
Decrease In Investments45.8M85.1M103.5M123.6M
 
 
 
 
 
Capital Expenditures-732.0K-656.0K-408.0K-947.0K
 
 
 
 
 
Net Cash Flow Investing-35.2M4.6M-65.0M43.3M
 
 
 
 
 
 
FinancingShort Term Borrowings--0.000.000.00--
Long Term Borrowings438.0K362.0K0.00440.0K
 
 
 
 
Long Term Debt Reduction-546.0K-282.0K-350.0K-313.0K
 
 
 
 
 
Net Proceeds Stock Sale61.7M44.2M134.0M52.3M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing18.0K0.000.000.00
 
 
Net Cash Flow - Financing61.5M44.3M133.6M52.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.000.00--
 
Net Change In Cash-9.3M2.4M14.9M40.2M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account